When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
HOLX - Hologic acquires cancer diagnostic tests provider for $230M
Hologic Inc.
Hologic (HOLX) has agreed to acquire Biotheranostics, a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, for ~$230M.Biotheranostics generated ~$33M of revenue in calendar 2020. The acquisition is expected to be slightly dilutive to Hologic’s non-GAAP EPS in fiscal 2021, break-even in 2022, and accretive thereafter.The deal is expected to close in February.